AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29909698 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 reading (awaken)
Number of subjects: 4277
Study 29909698 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 readings (asleep)
Number of subjects: 4277
Study 29909698 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 reading (asleep)
Number of subjects: 4277
Study 29909698 — intervention group
Group type: EXPERIMENTAL
Intervention: 10/5 mm Hg increments in systolic/diastolic ABP (awaken)
Number of subjects: 4277
Study 29909698 — intervention group
Group type: EXPERIMENTAL
Intervention: 10/5 mm Hg increments in systolic/diastolic ABP (asleep)
Number of subjects: 4277
Study 29909698 — intervention group
Group type: EXPERIMENTAL
Intervention: ≥8/≥4 readings (awaken/asleep)
Number of subjects: 4277
Study 28681550 — intervention group
Group type: EXPERIMENTAL
Intervention: AZL-M/CLD 40/12.5 mg/d (initial dose, could be uptitrated to 80/25 mg)
Number of subjects: 837
Study 28681550 — intervention group
Group type: EXPERIMENTAL
Intervention: AZL-M/CLD 40/12.5 mg/d
Number of subjects: 837
Study 28681550 — intervention group
Group type: COMPARATOR
Intervention: OLM/HCTZ 20/12.5 mg/d (initial dose, could be uptitrated to 40/25 mg or 20/25 mg)
Number of subjects: 837
Study 28681550 — intervention group
Group type: COMPARATOR
Intervention: OLM/HCTZ 20/12.5 mg/d
Number of subjects: 837
Study 28681550 — intervention group
Group type: EXPERIMENTAL
Intervention: AZL-M/CLD
Number of subjects: 837
Study 26322232 — intervention group
Group type: EXPERIMENTAL
Intervention: Stay active advice
Number of subjects: 99
Study 26322232 — intervention group
Group type: COMPARATOR
Intervention: Adjust activity advice
Number of subjects: 99
Study 22968852 — intervention group
Group type: COMPARATOR
Intervention: Cilostazol
Number of subjects: 20
Study 22968852 — intervention group
Group type: EXPERIMENTAL
Intervention: Sarpogrelate
Number of subjects: 20
Study 21789661 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin
Number of subjects: 59
Study 21789661 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 19137482 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapy interventions focusing on common factors and therapeutic alliance.
Number of subjects: 0
Study 19137482 — intervention group
Group type: COMPARATOR
Intervention: Randomized controlled trials (RCT) of psychotherapies.
Number of subjects: 0
Study 17460370 — intervention group
Group type: EXPERIMENTAL
Intervention: Benidipine added to ARB (Group A)
Number of subjects: 32
Study 17460370 — intervention group
Group type: EXPERIMENTAL
Intervention: Benidipine administered first, then ARB increased (Group B)
Number of subjects: 32
Study 17460370 — intervention group
Group type: COMPARATOR
Intervention: Cost-effectiveness comparison
Number of subjects: 32
Study 15502020 — intervention group
Group type: EXPERIMENTAL
Intervention: S(+)-ketamine (75 microg/kg bolus followed by continuous infusion of 1.25 microg . kg(‐1) . min(‐1) for 48 h)
Number of subjects: 90
Study 15502020 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline bolus and infusion)
Number of subjects: 90
Study 15502020 — intervention group
Group type: EXPERIMENTAL
Intervention: S(+)-ketamine
Number of subjects: 90
Study 15502020 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 11913480 — intervention group
Group type: EXPERIMENTAL
Intervention: Dofetilide 500 microg twice daily
Number of subjects: 135
Study 11913480 — intervention group
Group type: COMPARATOR
Intervention: Sotalol 160 mg twice daily
Number of subjects: 135
Study 9141577 — intervention group
Group type: EXPERIMENTAL
Intervention: Umbilical Doppler examination between 28 and 34 weeks of gestation
Number of subjects: 4187
Study 9141577 — intervention group
Group type: COMPARATOR
Intervention: No routine umbilical Doppler
Number of subjects: 4187
Study 7955239 — intervention group
Group type: EXPERIMENTAL
Intervention: Right internal thoracic artery (RITA) grafts
Number of subjects: 67
Study 7955239 — intervention group
Group type: EXPERIMENTAL
Intervention: Left internal thoracic artery (LITA) grafts
Number of subjects: 67
Study 7955239 — intervention group
Group type: EXPERIMENTAL
Intervention: RITA grafts to left anterior descending (LAD) coronary artery
Number of subjects: 67
Study 7955239 — intervention group
Group type: EXPERIMENTAL
Intervention: LITA grafts to left anterior descending (LAD) coronary artery
Number of subjects: 67
Study 7955239 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal thoracic arteries used to bypass vessels other than the LAD
Number of subjects: 67
Study 7955239 — intervention group
Group type: EXPERIMENTAL
Intervention: Free grafts using segments of the RITA
Number of subjects: 67
Study 7955239 — intervention group
Group type: EXPERIMENTAL
Intervention: Saphenous vein grafts
Number of subjects: 67
Study 3316311 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticarcillin disodium plus moxalactam (T+M)
Number of subjects: 53
Study 3316311 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin plus moxalactam (P+M)
Number of subjects: 53
Study 31597485 — intervention group
Group type: EXPERIMENTAL
Intervention: Pump bottle dispensing device
Number of subjects: 94
Study 31597485 — intervention group
Group type: COMPARATOR
Intervention: Squeeze bottle dispensing device
Number of subjects: 94
Study 31597485 — intervention group
Group type: EXPERIMENTAL
Intervention: Label treatments (two levels)
Number of subjects: 94
Study 30379244 — intervention group
Group type: EXPERIMENTAL
Intervention: Preheating with a forced air system for 20 minutes (38°C)
Number of subjects: 86
Study 30379244 — intervention group
Group type: COMPARATOR
Intervention: Usual care (heating with a cotton sheet and blanket)
Number of subjects: 86
Study 27878767 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous phenobarbital
Number of subjects: 73
Study 27878767 — intervention group
Group type: COMPARATOR
Intervention: Intravenous valproate
Number of subjects: 73
Study 25652672 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 38
Study 25652672 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 38
Study 24124503 — intervention group
Group type: EXPERIMENTAL
Intervention: Cogmed's RoboMemo program
Number of subjects: 67
Study 24124503 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 67
Study 21072756 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphorylcholine-coated tympanostomy tube
Number of subjects: 240
Study 21072756 — intervention group
Group type: COMPARATOR
Intervention: Uncoated tympanostomy tube
Number of subjects: 240
Study 19166423 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori eradication therapy (lansoprazole 30 mg, amoxicillin 1000 mg, and clarithromycin 500 mg, twice a day for 7 days)
Number of subjects: 47
Study 19166423 — intervention group
Group type: COMPARATOR
Intervention: Proton pump inhibitor (lansoprazole 30 mg, twice a day for 7 days)
Number of subjects: 47
Study 17054858 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous cytokine-induced killer cell (CIK) fusion (1.1 - 1.5 x 10^10) via peripheral vein or hepatic artery, administered once every 3 - 4 weeks for 4 times, then once every 4 weeks for 4 times
Number of subjects: 64
Study 17054858 — intervention group
Group type: COMPARATOR
Intervention: Control group (no CIK fusion)
Number of subjects: 64
Study 17054858 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous CIK fusion
Number of subjects: 64
Study 14642552 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored telephone counseling (TTC)
Number of subjects: 12905
Study 14642552 — intervention group
Group type: COMPARATOR
Intervention: Mailed reminders
Number of subjects: 12905
Study 10801994 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg/day
Number of subjects: 25
Study 10801994 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 8839716 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow Rotation (SR) chemotherapy
Number of subjects: 201
Study 8839716 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid Rotation (RR) chemotherapy
Number of subjects: 201
Study 8839716 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall group (SR + RR)
Number of subjects: 201
Study 8839716 — intervention group
Group type: EXPERIMENTAL
Intervention: Failure to achieve remission at day 28
Number of subjects: 201
Study 8839716 — intervention group
Group type: EXPERIMENTAL
Intervention: Children aged < 1 year
Number of subjects: 201
Study 8839716 — intervention group
Group type: EXPERIMENTAL
Intervention: Children aged 1-10 years
Number of subjects: 201
Study 8839716 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with WBC >= 100/nl in RR group
Number of subjects: 201
Study 1311152 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help dietary intervention introduced by a nurse
Number of subjects: 242
Study 1311152 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help dietary intervention for individuals responsible for meal preparation
Number of subjects: 242
Study 1311152 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 242
Study 1311152 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help dietary intervention
Number of subjects: 242
Study 6324832 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium trisilicate mixture B.P.C.
Number of subjects: 78
Study 6324832 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium citrate 0.3 mol litre‐1 mixture
Number of subjects: 78
Study 6324832 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 78
Study 30076171 — intervention group
Group type: EXPERIMENTAL
Intervention: ozanimod (treatment)
Number of subjects: 0
Study 30076171 — intervention group
Group type: COMPARATOR
Intervention: placebo (control)
Number of subjects: 0
Study 29394942 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported mental illness
Number of subjects: 437
Study 29394942 — intervention group
Group type: EXPERIMENTAL
Intervention: Being unemployed
Number of subjects: 437
Study 29394942 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall EQ-5D scores
Number of subjects: 437
Study 27427325 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental oxygen during exercise training
Number of subjects: 29
Study 27427325 — intervention group
Group type: COMPARATOR
Intervention: Compressed medical air during exercise training (control)
Number of subjects: 29
Study 27427325 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training with supplemental oxygen
Number of subjects: 29
Study 25209738 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous drisapersen 6 mg/kg
Number of subjects: 53
Study 25209738 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent drisapersen 6 mg/kg
Number of subjects: 53
Study 25209738 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 22732469 — intervention group
Group type: EXPERIMENTAL
Intervention: Cobicistat (COBI) 150 mg QD for 7 days
Number of subjects: 54
Study 22732469 — intervention group
Group type: COMPARATOR
Intervention: Ritonavir (RTV) 100 mg QD for 7 days
Number of subjects: 54
Study 22732469 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 7 days
Number of subjects: 54
Study 19906767 — intervention group
Group type: COMPARATOR
Intervention: Cane use
Number of subjects: 13
Study 19906767 — intervention group
Group type: EXPERIMENTAL
Intervention: TheraTogs
Number of subjects: 13
Study 19906767 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip abductor taping
Number of subjects: 13
Study 19906767 — intervention group
Group type: COMPARATOR
Intervention: Baseline (without aids)
Number of subjects: 13
Study 17898345 — intervention group
Group type: EXPERIMENTAL
Intervention: Earlier ages at onset of major depressive disorder
Number of subjects: 4041
Study 17898345 — intervention group
Group type: EXPERIMENTAL
Intervention: Age at onset
Number of subjects: 4041
Study 15173480 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive home safety education and free safety devices
Number of subjects: 96
Study 15173480 — intervention group
Group type: COMPARATOR
Intervention: Focused, injury-specific ED discharge instructions
Number of subjects: 96
Study 11534317 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (Dalteparin) at a dose of 200 I.E./kg body weight/d
Number of subjects: 138
Study 11534317 — intervention group
Group type: COMPARATOR
Intervention: Unfragmented heparin
Number of subjects: 138
Study 9508182 — intervention group
Group type: EXPERIMENTAL
Intervention: Goserelin (3.6 mg subcutaneously every 4 weeks; n = 69)
Number of subjects: 138
Study 9508182 — intervention group
Group type: COMPARATOR
Intervention: Surgical ovariectomy (n = 67)
Number of subjects: 138
Study 9508182 — intervention group
Group type: EXPERIMENTAL
Intervention: Goserelin
Number of subjects: 138
Study 7999651 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle set A (16-gauge Tuohy needle and a 26-gauge spinal needle that extends 13 mm beyond the tip of the Tuohy needle)
Number of subjects: 40
Study 7999651 — intervention group
Group type: COMPARATOR
Intervention: Needle set B (16-gauge Tuohy needle with an aperture in its curve for the insertion of a 26-gauge spinal needle that protrudes 10 mm beyond the tip of the epidural needle)
Number of subjects: 40
Study 7999651 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined spinal-epidural anesthesia
Number of subjects: 40
Study 7999651 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion of bupivacaine (0.1%) with fentanyl (2 micrograms/mL)
Number of subjects: 40
Study 2667633 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxybutinin hydrochloride
Number of subjects: 23
Study 2667633 — intervention group
Group type: COMPARATOR
Intervention: Propanthiline bromide
Number of subjects: 23
Study 4207904 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative irradiation followed by surgery
Number of subjects: 3
Study 4207904 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative irradiation followed by surgery
Number of subjects: 3
Study 4207904 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 3
Study 31214836 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanthanum carbonate (LC)
Number of subjects: 65
Study 31214836 — intervention group
Group type: COMPARATOR
Intervention: Calcium carbonate (CC)
Number of subjects: 65
Study 27546817 — intervention group
Group type: EXPERIMENTAL
Intervention: Indapamide SR 1.5 mg with perindopril 2-4 mg (active treatment)
Number of subjects: 139
Study 27546817 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 139
Study 25639993 — intervention group
Group type: EXPERIMENTAL
Intervention: Housing First
Number of subjects: 950
Study 25639993 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 950
Study 22717145 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist behaviours in internet-delivered cognitive behaviour therapy (iCBT)
Number of subjects: 44
Study 21641117 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal cognitive behavioral stress management (CBSM) intervention
Number of subjects: 86
Study 21641117 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 86
Study 21641117 — intervention group
Group type: COMPARATOR
Intervention: Low risk comparison (LRC) group
Number of subjects: 86
Study 19892237 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical valve (MP)
Number of subjects: 310
Study 19892237 — intervention group
Group type: COMPARATOR
Intervention: Bioprosthetic valve (BP)
Number of subjects: 310
Study 16328904 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Generated Index (PGI) at 6 and 24 weeks post-stroke
Number of subjects: 92
Study 12221157 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon beta-1a (60 micro g)
Number of subjects: 436
Study 12221157 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 436
Study 9865236 — intervention group
Group type: EXPERIMENTAL
Intervention: 2,3-dimercaptosuccinic acid 1400 mg/d (1000 mg/m2) in the first week and 1050 mg/d (750 mg/m2) during the next 2 weeks with a repeat course 3 weeks later
Number of subjects: 21
Study 9865236 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules for the same schedule
Number of subjects: 21
Study 7890238 — intervention group
Group type: EXPERIMENTAL
Intervention: Oligopeptide diet
Number of subjects: 44
Study 7890238 — intervention group
Group type: COMPARATOR
Intervention: Amino acid diet
Number of subjects: 44
Study 2090833 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 0
Study 2090833 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 0
Study 377130 — intervention group
Group type: EXPERIMENTAL
Intervention: ionic contrast media
Number of subjects: 0
Study 377130 — intervention group
Group type: COMPARATOR
Intervention: non-ionic contrast media (implied control)
Number of subjects: 0
Study 31947784 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdisciplinary program (healthy eating, exercise, cognitive behavioral therapy)
Number of subjects: 74
Study 31947784 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdisciplinary program
Number of subjects: 74
Study 30289426 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral weight loss (BWL) treatment
Number of subjects: 110
Study 30289426 — intervention group
Group type: COMPARATOR
Intervention: Migraine education (ME)
Number of subjects: 110
Study 24899570 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral preparation containing hyaluronic acid (Oralvisc®)
Number of subjects: 40
Study 24899570 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 40
Study 22903518 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG-biofeedback
Number of subjects: 38
Study 22903518 — intervention group
Group type: COMPARATOR
Intervention: SC-biofeedback
Number of subjects: 38
Study 22903518 — intervention group
Group type: COMPARATOR
Intervention: Waiting list
Number of subjects: 38
Study 21934454 — intervention group
Group type: EXPERIMENTAL
Intervention: Contraceptive curriculum (hormonal contraceptives provided onsite at no cost)
Number of subjects: 889
Study 19164788 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (1 mg/kg bolus followed by continuous infusion for 48 hours)
Number of subjects: 277
Study 19164788 — intervention group
Group type: COMPARATOR
Intervention: Placebo (bolus and infusion)
Number of subjects: 277
Study 19164788 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (total dose mg/kg)
Number of subjects: 277
Study 19164788 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (lower doses)
Number of subjects: 277
Study 18033941 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based instruction for anatomical interpretation in maxillofacial cone beam CT (CBCT)
Number of subjects: 3
Study 15306109 — intervention group
Group type: EXPERIMENTAL
Intervention: Cialis 20 mg taken on demand
Number of subjects: 443
Study 15306109 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 443
Study 11884002 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous Endoscopic Gastrostomy (PEG)
Number of subjects: 122
Study 11884002 — intervention group
Group type: COMPARATOR
Intervention: Nasogastric Tube (NGT)
Number of subjects: 122
Study 9498886 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 1.0 mg/kgxh
Number of subjects: 24
Study 9498886 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 1.5 mg/kgxh
Number of subjects: 24
Study 9498886 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 2.0 mg/kgxh
Number of subjects: 24
Study 9498886 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 0.1 mg/kg bolus followed by 1.0 mg/kgxh
Number of subjects: 24
Study 8192438 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 g of oral acyclovir daily
Number of subjects: 139
Study 8192438 — intervention group
Group type: COMPARATOR
Intervention: 1 g of oral acyclovir daily
Number of subjects: 139
Study 8192438 — intervention group
Group type: EXPERIMENTAL
Intervention: Both doses of acyclovir
Number of subjects: 139
Study 3359913 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigilance
Number of subjects: 40
Study 3359913 — intervention group
Group type: EXPERIMENTAL
Intervention: Rest
Number of subjects: 40
Study 3359913 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress
Number of subjects: 40
Study 3359913 — intervention group
Group type: EXPERIMENTAL
Intervention: After a meal
Number of subjects: 40
Study 3359913 — intervention group
Group type: EXPERIMENTAL
Intervention: Stationary spiking activity during Vigilance
Number of subjects: 40
Study 3359913 — intervention group
Group type: EXPERIMENTAL
Intervention: Stationary spiking activity during Rest
Number of subjects: 40
Study 3359913 — intervention group
Group type: EXPERIMENTAL
Intervention: Stationary spiking activity during Stress
Number of subjects: 40
Study 3359913 — intervention group
Group type: EXPERIMENTAL
Intervention: Stationary spiking activity after a meal
Number of subjects: 40
Study 29235894 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacritinib
Number of subjects: 0
Study 29235894 — intervention group
Group type: COMPARATOR
Intervention: Ruxolitinib
Number of subjects: 0
Study 26823552 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoanalogue‐supplemented vegetarian very low‐protein diet (KD) (0.3 g/kg vegetable proteins and 1 cps/5 kg ketoanalogues per day)
Number of subjects: 0
Study 26823552 — intervention group
Group type: COMPARATOR
Intervention: Conventional low‐protein diet (LPD) (0.6 g/kg per day)
Number of subjects: 0
Study 26823552 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoanalogue‐supplemented vegetarian very low‐protein diet (KD)
Number of subjects: 0
Study 23621351 — intervention group
Group type: EXPERIMENTAL
Intervention: Calvarial bone blocks (group 1)
Number of subjects: 9
Study 23621351 — intervention group
Group type: COMPARATOR
Intervention: Iliac crest bone grafts (group 2)
Number of subjects: 9
Study 24401580 — intervention group
Group type: EXPERIMENTAL
Intervention: P(cv‐a) CO2 guided fluid therapy (group P)
Number of subjects: 40
Study 24401580 — intervention group
Group type: COMPARATOR
Intervention: ScvO2 guided fluid therapy (group S)
Number of subjects: 40
Study 20150206 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet based on increased consumption of fresh fruit and vegetables (intervention group)
Number of subjects: 120
Study 20150206 — intervention group
Group type: COMPARATOR
Intervention: Free diet (control group)
Number of subjects: 120
Study 18006187 — intervention group
Group type: EXPERIMENTAL
Intervention: Suppression of thoughts of eating chocolate
Number of subjects: 134
Study 18006187 — intervention group
Group type: EXPERIMENTAL
Intervention: Expression of thoughts of eating chocolate
Number of subjects: 134